Table 1 Demographic and clinical features of patients
Characteristic | N = 322 | Characteristic | N = 322 |
|---|---|---|---|
Age (years) | 62.3 ± 9.9 | CRP on POD 3 (mg/L) | 96.7 ± 59.5 |
Gender (n) | ALB on POD 3 (g/L) | 32.9 ± 3.6 | |
Male | 232 | ASA ≥ 3 | 171 |
Female | 90 | Clinical stage I/II/III/IV | 101/58/148/15 |
BMI (kg/m2) | 23.0 ± 3.3 | Mode of surgical approach (n, %) | |
Comorbidities (n) | Laparoscopic | 22 | |
Diabetes mellitus | 20 | Open | 300 |
Hypertension | 111 | Type of resection (n, %) | |
Preoperative serum albumin (g/L) | 38.6 ± 3.2 | Distal gastrectomy | 114 |
Preoperative hemoglobin (g/L) | 123.1 ± 25.2 | Proximal gastrectomy | 38 |
Preoperative CRP (g/L) | 6.2 ± 10.4 | Total gastrectomy | 170 |
CA 19–9 (ng/ml) | Degree of lymph node dissection (D) ≥ 2 | 246 | |
≥ 37 | 60 | Operation time (min) | 236.7 ± 65.7 |
< 37 | 262 | Blood loss (ml) | 229.6 ± 145.5 |
CEA (ng/ml) | Postoperative complications (Clavien-Dindo) | ||
≥ 5 | 39 | Grades I and II | 56 |
< 5 | 283 | ≥ Grade III | 29 |
Lymphocyte count (×109/L) | Postoperative stay (days) | 15.4 ± 7.8 | |
≥ 3 | 13 | ||
< 3 | 309 |